公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2015 | Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis | Lim K.-H.; Chang Y.-C.; Gon-Shen Chen C.; Lin H.-C.; Wang W.-T.; Chiang Y.-H.; Cheng H.-I.; Su N.-W.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; Kuo Y.-Y.; WEN-CHIEN CHOU | Blood Cancer Journal | 23 | 25 | |
2015 | Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: A multicenter prospective Phase II trial | Hsieh J.C.; Hsu C.-L.; Ng S.-H.; Wang C.-H.; Lee K.-D.; Lu C.-H.; Chang Y.-F.; Hsieh R.-K.; KUN-HUEI YEH ; Hsiao C.-H.; Chen S.-Y.; Shiau C.-Y.; Wang H.-M. | Japanese Journal of Clinical Oncology | 18 | 19 | |
2017 | Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population | Chiang Y.-H.; Chang Y.-C.; Lin H.-C.; Huang L.; Cheng C.-C.; Wang W.-T.; Cheng H.-I.; Su N.-W.; Chen C.G.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; WEN-CHIEN CHOU ; Lim K.-H.; YUAN-YEH KUO | Oncotarget | 11 | 9 | |
2008 | High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy | Perng R.-P.; CHIH-HSIN YANG ; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; CHONG-JEN YU ; Chang W.-C.; Kuo H.-P.; Yu C.-T.; ZHONG-ZHE LIN ; Kao W.-Y. | Lung Cancer | 28 | 26 | |
2011 | Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study | Ch'Ang H.-J.; Lin Y.-L.; HSIU-PO WANG ; Chiu Y.-F.; MING-CHU CHANG ; CHIH-HUNG HSU ; YU-WEN TIEN ; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG ; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. | International Journal of Radiation Oncology Biology Physics | 19 | 17 | |
2014 | Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response | De Azambuja E.; Holmes A.P.; Piccart-Gebhart M.; Holmes E.; Di Cosimo S.; Swaby R.F.; Untch M.; Jackisch C.; Lang I.; Smith I.; Boyle F.; Xu B.; Barrios C.H.; Perez E.A.; Azim H.A.; Kim S.-B.; Kuemmel S.; CHIUN-SHENG HUANG ; Vuylsteke P.; Hsieh R.-K.; Gorbunova V.; Eniu A.; Dreosti L.; Tavartkiladze N.; Gelber R.D.; Eidtmann H.; Baselga J. | The Lancet Oncology | 384 | 330 | |
2015 | The law of Yin and Yang for controlled drugs ecosystem: Maximal analgesia with minimal abuse | WEI-ZEN SUN ; Hsieh Y.-J.; Lin C.-S.; YEUR-HUR LAI ; Chien S.-C.; Wang C.-W.; Hsieh R.-K.; Taiwan Pain Forum | Acta Anaesthesiologica Taiwanica | 0 | 0 | |
2020 | A nationwide survey of fatigue in cancer patients in Taiwan: An unmet need | Rau K.-M.; Rau K.-M.; SHIOW-CHING SHUN ; Chiou T.-J.; Lu C.-H.; Lu C.-H.; Ko W.-H.; Ko W.-H.; Lee M.-Y.; Huang W.-T.; KUN-HUEI YEH ; Chang C.-S.; Chang C.-S.; Hsieh R.-K. | Japanese Journal of Clinical Oncology | 9 | 9 | |
2011 | A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan | Chen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG ; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; KUN-HUEI YEH ; Chen L.-T.; Whang-Peng J. | Cancer Chemotherapy and Pharmacology | 6 | 5 | |
2009 | A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting | Ho C.-L.; Su W.-C.; Hsieh R.-K.; ZHONG-ZHE LIN ; Chao T.-Y. | Japanese Journal of Clinical Oncology | 16 | 15 | |
1989 | Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy | Tzeng C.-H.; Chen P.-M.; Chuang M.-W.; Liu J.-H.; Hsieh R.-K.; CHUN-JEN LIU ; Fan S.; Chen K.Y.; Yung C.-H.; Wang S.-Y.; Chau W.-K.; Ching K.-N. | Chinese Medical Journal (Taipei) | 4 | 0 | |
2012 | Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study | CHIUN HSU ; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; CHIH-WEI YU ; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; ANN-LII CHENG | Journal of Hepatology | 79 | 74 | |
1997 | Weekly CAF chemotherapy for advanced breast cancer patients | Hwang W.-S.; Hsiung C.A.; Ko W.-S.; lVang C.-C.; Chang J.-V.; Lai G.-M.; Hsieh R.-K.; Tsao C.-J.; Chen L.-T.; Law C.-K.; ANN-LII CHENG ; Fan S.F.; Tzeng C.-H.; Chiou T.-J.; Whang-Peng J. | Oncology (Switzerland) | 1 | 1 | |